Research Output per year
Fingerprint Dive into the research topics where Marco Paulli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 23 Similar Profiles
Lymphoma
Medicine & Life Sciences
Lymphoproliferative Disorders
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Skin
Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1984 2020
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis
Basset, M., Defrancesco, I., Milani, P., Nuvolone, M., Rattotti, S., Foli, A., Mangiacavalli, S., Varettoni, M., Benvenuti, P., Cartia, C. S., Paulli, M., Merlini, G., Arcaini, L. & Palladini, G., Jan 23 2020, In : Blood. 135, 4, p. 293-296 4 p.Research output: Contribution to journal › Article
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)
Di Napoli, A., Remotti, D., Agostinelli, C., Ambrosio, M. R., Ascani, S., Carbone, A., Facchetti, F., Lazzi, S., Leoncini, L., Lucioni, M., Novero, D., Pileri, S., Ponzoni, M., Sabattini, E., Tripodo, C., Zamò, A., Paulli, M. & Ruco, L., Jan 1 2019, In : Virchows Archiv.Research output: Contribution to journal › Article
B-Cell Lymphoma
Cytogenetics
Therapeutics
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders
Varettoni, M., Zibellini, S., Boveri, E., Klersy, C., Candido, C., Rattotti, S., Ferretti, V. V., Defrancesco, I., Mangiacavalli, S., Nizzoli, M. E., Flospergher, E., Zerbi, C., Bergamini, F., Benvenuti, P., Brociner, M., Merati, G., Paulli, M. & Arcaini, L., Jan 1 2019, In : British Journal of Haematology.Research output: Contribution to journal › Article
Monoclonal Gammopathy of Undetermined Significance
Waldenstrom Macroglobulinemia
Lymphoproliferative Disorders
Immunoglobulin M
Blood Proteins
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Sapienza, M. R., Abate, F., Melle, F., Orecchioni, S., Fuligni, F., Etebari, M., Tabanelli, V., Laginestra, M. A., Pileri, A., Motta, G., Rossi, M., Agostinelli, C., Sabattini, E., Pimpinelli, N., Truni, M., Falini, B., Cerroni, L., Talarico, G., Piccioni, R., Amente, S. & 11 others, , 2019, In : Haematologica. 104, 4, p. 729-737 9 p.Research output: Contribution to journal › Article
Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target
Sapienza, M. R., Abate, F., Melle, F., Orecchioni, S., Fuligni, F., Etebari, M., Tabanelli, V., Laginestra, M. A., Pileri, A., Motta, G., Rossi, M., Agostinelli, C., Sabattini, E., Pimpinelli, N., Truni, M., Falini, B., Cerroni, L., Talarico, G., Piccioni, R., Amente, S. & 11 others, , 2019, In : Haematologica. 104, 4, p. 729-737 9 p.Research output: Contribution to journal › Article
Genomics
Epigenomics
Dendritic Cells
Exome
Hematologic Neoplasms